Growth Stock Analytics-High EPS and Relative Strength Stock Market Trading System Growth Stock Analytics-High EPS and Relative Strength Stock Market Trading System
Growth Stock Investing and Trading for Stock Market Investors - Since 1996 | MyStockScreen.com | Home | Join Now | Member Login | Refer a Friend | Contact Us
Your Best Source For Top Stock Picks, Stock Rankings, Stock Screening, Swing Trading, Market Direction and More...
HI-EPSRS
Screener
My Watch
List
Market
Direction
Industry
Map
My
Account
Help Logout
Symbol:
Enter Symbols Separated By Spaces.
Download All Symbols To Text/CSV

Top Picks Watch List
Dist.Days: SPY:4 DOW:4 QQQ:2

GSA Live Portfolio:
FNSR PRO
2022-11-08: We have a signal to move out of CASH and into FBSOX....Read more

HI-EPSRS Database Search Results   

Search Results      Stocks 1 through 9 of 9 shown        Download Search Results Symbols To Text/CSV

Abiomed Inc (ABMD)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.6/1.0
Sales
Consistency

Sales Consistency Ranking

1.0/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

4/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

5%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
80.07
Acc Dist
1.46
Disc
163.59%
Avg Vol
322,000
Liquidity
0.79%
Below High
0.13%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
170%  183%
EPS Growth
77%
Sls Growth
30%
Proj Growth
31.5%
Anal. Rank
4.38
Shares
44.2M
Instit
92%
3-Month Trends of Key Indicators:
Looks Like a Winner?
ABMD looks better than most Top Picks Winners* in 4 out of 10 key factors.
Accum/Dist: 1.46 (median winner: 1.53)
Above 40wkMA: 34% (median winner: 35%)
Instit. Ownership: 92% (median winner: 63%)
Liquidity: 0.79% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 80.07 (winner: 75.66)
Sales Growth: 30% (median winner: 28%)
Below 52wk High: 0.13% (winner: 3.30%)
Relative Strength: 95 (winner: 96)
Avg Qrtly EPS: 176% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

  • ETFs with exposure to ABIOMED, Inc. : November 24, 2017 Fri, 24 Nov 2017 15:20:02 +0000
    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ABIOMED, Inc. Here are 5 ETFs with the largest exposure to ABMD-US. Comparing the performance and risk of ABIOMED, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
  • 7 Tech Stocks to Buy That Sport Amazon-Like Growth Fri, 10 Nov 2017 17:51:37 +0000
    There’s no doubt that we continue to be in a growth-fueled market. This hasn’t always been the case. In case you’ve forgotten, after the financial meltdown, it was dividend stocks that were the ‘new’ growth stocks. Everyone was scrambling for dividends, and not surprisingly, many stocks began to offer tantalizing dividends.
  • ABIOMED, Inc. :ABMD-US: Earnings Analysis: Q2, 2018 By the Numbers : November 8, 2017 Wed, 08 Nov 2017 19:27:52 +0000
    Categories: Yahoo FinanceGet free summary analysis ABIOMED, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of ABIOMED, Inc. – Teleflex Incorporated, Boston Scientific Corporation and AtriCure, Inc. (TFX-US, BSX-US and ATRC-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 132.82 ... Read more (Read more...)
  • Abiomed (ABMD) Looks Good: Stock Adds 7.5% in Session Wed, 01 Nov 2017 12:35:12 +0000
    Abiomed (ABMD) was a big mover last session, as the company saw its shares rise more than 7% on the day amid huge volumes.
  • Top Ranked Momentum Stocks to Buy for October 31st Tue, 31 Oct 2017 15:32:03 +0000
    Top Ranked Momentum Stocks to Buy for October 31st
  • Abiomed (ABMD) Earnings and Revenues Beat Estimates in Q2 Mon, 30 Oct 2017 11:56:11 +0000
    Abiomed's (ABMD) strong performance in Impella heart pump boosted the company's second-quarter 2018 results.
  • Company News For Oct 27, 2017 Fri, 27 Oct 2017 14:17:02 +0000
    Companies in the news are: TWTR,F,BMY,ABMD
  • Abiomed beats Street 2Q forecasts Thu, 26 Oct 2017 11:35:30 +0000
    The Danvers, Massachusetts-based company said it had profit of 54 cents per share. Earnings, adjusted for non-recurring gains, were 44 cents per share. The results exceeded Wall Street expectations. The ...
  • See what the IHS Markit Score report has to say about Abiomed Inc. Tue, 17 Oct 2017 12:07:12 +0000
    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
  • Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark Wed, 11 Oct 2017 07:00:00 +0000
    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
ABMD EPS/Sales Growth ABMD vs. Peers

Inogen Inc (INGN)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.7/1.0
Sales
Consistency

Sales Consistency Ranking

0.8/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

4/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

7%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
75.62
Acc Dist
0.85
Disc
418.25%
Avg Vol
156,400
Liquidity
0.63%
Below High
0.14%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
32%  8%
EPS Growth
60%
Sls Growth
43%
Proj Growth
20%
Anal. Rank
4.50
Shares
20.9M
Instit
0%
3-Month Trends of Key Indicators:
Looks Like a Winner?
INGN looks better than most Top Picks Winners* in 4 out of 10 key factors.
Accum/Dist: 0.85 (median winner: 1.53)
Above 40wkMA: 36% (median winner: 35%)
Instit. Ownership: 0% (median winner: 63%)
Liquidity: 0.63% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 75.62 (winner: 75.66)
Sales Growth: 43% (median winner: 28%)
Below 52wk High: 0.14% (winner: 3.30%)
Relative Strength: 95 (winner: 96)
Avg Qrtly EPS: 20% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

Reclaim your independence with a lightweight portable oxygen concentrator for oxygen therapy from Inogen. Find your freedom to breathe anytime, anywhere.

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
INGN EPS/Sales Growth INGN vs. Peers

Haemonetics Corp (HAE)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.1/1.0
Sales
Consistency

Sales Consistency Ranking

0.0/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

4/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

27%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
75.47
Acc Dist
1.18
Disc
339.08%
Avg Vol
376,400
Liquidity
0.77%
Below High
0.37%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
0%  290%
EPS Growth
0%
Sls Growth
0%
Proj Growth
7.8%
Anal. Rank
3.21
Shares
52.8M
Instit
0%
3-Month Trends of Key Indicators:
Looks Like a Winner?
HAE looks better than most Top Picks Winners* in 4 out of 10 key factors.
Accum/Dist: 1.18 (median winner: 1.53)
Above 40wkMA: 37% (median winner: 35%)
Instit. Ownership: 0% (median winner: 63%)
Liquidity: 0.77% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 75.47 (winner: 75.66)
Sales Growth: 0% (median winner: 28%)
Below 52wk High: 0.37% (winner: 3.30%)
Relative Strength: 94 (winner: 96)
Avg Qrtly EPS: 145% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

Haemonetics is a global company that markets automated blood processing systems. These systems help increase the safety, quality and availability of the world blood supply by addressing important medical markets: surgical blood salvage, blood component collections and plasma collections.

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
HAE EPS/Sales Growth HAE vs. Peers

Insulet Corp (PODD)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.4/1.0
Sales
Consistency

Sales Consistency Ranking

1.0/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

3/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

0%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
71.69
Acc Dist
2.10
Disc
0.00%
Avg Vol
622,100
Liquidity
1.15%
Below High
4.01%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
50%  -100%
EPS Growth
0%
Sls Growth
15%
Proj Growth
N/A %
Anal. Rank
3.98
Shares
58.2M
Instit
0%
3-Month Trends of Key Indicators:
Looks Like a Winner?
PODD looks better than most Top Picks Winners* in 3 out of 10 key factors.
Accum/Dist: 2.10 (median winner: 1.53)
Above 40wkMA: 36% (median winner: 35%)
Instit. Ownership: 0% (median winner: 63%)
Liquidity: 1.15% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 71.69 (winner: 75.66)
Sales Growth: 15% (median winner: 28%)
Below 52wk High: 4.01% (winner: 3.30%)
Relative Strength: 95 (winner: 96)
Avg Qrtly EPS: -25% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

Insulet Corporation (Nasdaq: PODD) is an innovative medical device company dedicated to improving the lives of people with diabetes. The Companys OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

  • See what the IHS Markit Score report has to say about Insulet Corp. Wed, 22 Nov 2017 13:05:03 +0000
    Insulet Corp NASDAQ/NGS:PODD
  • Insulet Corporation to Present at Upcoming Investor Conference Wed, 22 Nov 2017 13:00:00 +0000
    Insulet Corporation , the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference in New York City, New York on November 28, 2017, at 12:30pm .
  • ETFs with exposure to Insulet Corp. : November 13, 2017 Mon, 13 Nov 2017 18:02:24 +0000
    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Insulet Corp. Here are 5 ETFs with the largest exposure to PODD-US. Comparing the performance and risk of Insulet Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
  • Edited Transcript of PODD earnings conference call or presentation 2-Nov-17 8:30pm GMT Thu, 09 Nov 2017 09:41:03 +0000
    Q3 2017 Insulet Corp Earnings Call
  • Insulet Announces Pricing of Convertible Senior Notes Due 2024 Wed, 08 Nov 2017 12:15:00 +0000
    Insulet Corporation  , a leader in tubeless insulin pump technology with its Omnipod® Insulin Management System , has priced a private placement of $350 million principal amount of convertible senior notes due 2024 .
  • Insulet Corp. :PODD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Tue, 07 Nov 2017 13:13:14 +0000
    Categories: Yahoo FinanceGet free summary analysis Insulet Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Insulet Corp. – Tandem Diabetes Care, Inc., DexCom, Inc., Eli Lilly and Company, Abbott Laboratories and Johnson & Johnson (TNDM-US, DXCM-US, LLY-US, ABT-US and JNJ-US) that have also reported ... Read more (Read more...)
  • Insulet Corp. breached its 50 day moving average in a Bullish Manner : PODD-US : November 6, 2017 Mon, 06 Nov 2017 12:19:10 +0000
    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Insulet Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)
  • Insulet Corporation (Nasdaq: PODD) to Ring The Nasdaq Stock Market Closing Bell Fri, 03 Nov 2017 14:00:00 +0000
    What: Insulet Corporation, an innovative medical device company dedicated to making the lives of people with diabetes easier, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, ...
  • Insulet reports 3Q loss Thu, 02 Nov 2017 20:59:01 +0000
    On a per-share basis, the Billerica, Massachusetts-based company said it had a loss of 4 cents. The results exceeded Wall Street expectations. The average estimate of 14 analysts surveyed by Zacks Investment ...
  • Insulet Reports Third Quarter 2017 Financial Results Thu, 02 Nov 2017 20:01:00 +0000
    Insulet Corporation , the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System , today announced financial results for the three months ended September 30, 2017.

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
PODD EPS/Sales Growth PODD vs. Peers

Becton Dickinson & Co (BDX)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.0/1.0
Sales
Consistency

Sales Consistency Ranking

0.4/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

2/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

4%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
70.84
Acc Dist
1.32
Disc
75.54%
Avg Vol
1,121,400
Liquidity
0.51%
Below High
0.54%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
1450%  -144%
EPS Growth
19%
Sls Growth
13%
Proj Growth
12%
Anal. Rank
4.00
Shares
228M
Instit
90%
3-Month Trends of Key Indicators:
Looks Like a Winner?
BDX looks better than most Top Picks Winners* in 2 out of 10 key factors.
Accum/Dist: 1.32 (median winner: 1.53)
Above 40wkMA: 16% (median winner: 35%)
Instit. Ownership: 90% (median winner: 63%)
Liquidity: 0.51% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 70.84 (winner: 75.66)
Sales Growth: 13% (median winner: 28%)
Below 52wk High: 0.54% (winner: 3.30%)
Relative Strength: 84 (winner: 96)
Avg Qrtly EPS: 653% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

BD (Becton, Dickinson and Company) is a medical technology company that manufactures medical supplies, devices, laboratory equipment and diagnostic products for healthcare institutions, research laboratories, industry and the general public.

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
BDX EPS/Sales Growth BDX vs. Peers

ICU Medical Inc (ICUI)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.0/1.0
Sales
Consistency

Sales Consistency Ranking

0.7/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

2/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

21%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
70.16
Acc Dist
1.56
Disc
197.78%
Avg Vol
103,500
Liquidity
0.55%
Below High
0.25%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
-101%  -299%
EPS Growth
-18%
Sls Growth
5%
Proj Growth
15.8%
Anal. Rank
3.50
Shares
20.1M
Instit
86%
3-Month Trends of Key Indicators:
Looks Like a Winner?
ICUI looks better than most Top Picks Winners* in 2 out of 10 key factors.
Accum/Dist: 1.56 (median winner: 1.53)
Above 40wkMA: 27% (median winner: 35%)
Instit. Ownership: 86% (median winner: 63%)
Liquidity: 0.55% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 70.16 (winner: 75.66)
Sales Growth: 5% (median winner: 28%)
Below 52wk High: 0.25% (winner: 3.30%)
Relative Strength: 91 (winner: 96)
Avg Qrtly EPS: -200% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

  • Edited Transcript of ICUI earnings conference call or presentation 9-Nov-17 9:30pm GMT Fri, 24 Nov 2017 07:57:42 +0000
    Q3 2017 ICU Medical Inc Earnings Call
  • See what the IHS Markit Score report has to say about ICU Medical Inc. Thu, 23 Nov 2017 13:07:03 +0000
    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
  • ICU Medical, Inc. – Value Analysis (NASDAQ:ICUI) : November 14, 2017 Tue, 14 Nov 2017 20:29:27 +0000
    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ICU Medical, Inc. a score of 63. Our analysis is based on comparing ICU Medical, Inc. with the following peers – Merit Medical Systems, Inc., Edwards Lifesciences Corporation, AngioDynamics, Inc., Insulet Corporation, Delcath Systems, Inc., Teleflex Incorporated, Becton, Dickinson and Company and Baxter International Inc. (MMSI-US, EW-US, ... Read more (Read more...)
  • This Simple, Lifesaving Liquid Is Suddenly in Short Supply Tue, 14 Nov 2017 11:00:15 +0000
    A dangerous shortage of saline bags, years in the making, has gotten worse after Hurricane Maria knocked out factories in Puerto Rico.
  • ICU Medical (ICUI) in Focus: Stock Moves 10.2% Higher Mon, 13 Nov 2017 13:40:01 +0000
    ICU Medical (ICUI) saw its shares rise over 10% on the day.
  • ICU Medical, Inc. breached its 50 day moving average in a Bullish Manner : ICUI-US : November 13, 2017 Mon, 13 Nov 2017 12:25:18 +0000
    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ICU Medical, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)
  • ETFs with exposure to ICU Medical, Inc. : November 10, 2017 Fri, 10 Nov 2017 17:36:07 +0000
    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ICU Medical, Inc. Here are 5 ETFs with the largest exposure to ICUI-US. Comparing the performance and risk of ICU Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
  • ICU Medical posts 3Q profit Thu, 09 Nov 2017 23:27:52 +0000
    The San Clemente, California-based company said it had profit of 1 cent per share. Earnings, adjusted for non-recurring costs and stock option expense, came to $1.12 per share. The medical device maker ...
  • ICU Medical, Inc. Announces Third Quarter 2017 Results Thu, 09 Nov 2017 21:05:00 +0000
    SAN CLEMENTE, Calif., Nov. 09, 2017-- ICU Medical, Inc., a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced ...
  • ICU Medical, Inc. to Host Earnings Call Thu, 09 Nov 2017 17:00:00 +0000
    NEW YORK, NY / ACCESSWIRE / November 9, 2017 / ICU Medical, Inc. (NASDAQ: ICUI ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 9, 2017 at 4:30 PM Eastern Time. ...

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
ICUI EPS/Sales Growth ICUI vs. Peers

PerkinElmer Inc (PKI)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.3/1.0
Sales
Consistency

Sales Consistency Ranking

0.0/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

2/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

5%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
62.31
Acc Dist
1.30
Disc
118.19%
Avg Vol
527,400
Liquidity
0.47%
Below High
0.10%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
55%  219%
EPS Growth
41%
Sls Growth
0%
Proj Growth
11.6%
Anal. Rank
3.39
Shares
110M
Instit
99%
3-Month Trends of Key Indicators:
Looks Like a Winner?
PKI looks better than most Top Picks Winners* in 2 out of 10 key factors.
Accum/Dist: 1.30 (median winner: 1.53)
Above 40wkMA: 13% (median winner: 35%)
Instit. Ownership: 99% (median winner: 63%)
Liquidity: 0.47% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 62.31 (winner: 75.66)
Sales Growth: 0% (median winner: 28%)
Below 52wk High: 0.10% (winner: 3.30%)
Relative Strength: 85 (winner: 96)
Avg Qrtly EPS: 137% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

PerkinElmer Life and Analytical Sciences

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
PKI EPS/Sales Growth PKI vs. Peers

Merit Medical Systems Inc (MMSI)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.0/1.0
Sales
Consistency

Sales Consistency Ranking

0.9/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

1/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

22%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
58.23
Acc Dist
1.00
Disc
196.82%
Avg Vol
391,400
Liquidity
0.81%
Below High
3.08%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
-500%  13%
EPS Growth
16%
Sls Growth
11%
Proj Growth
11.6%
Anal. Rank
4.46
Shares
50.2M
Instit
95%
3-Month Trends of Key Indicators:
Looks Like a Winner?
MMSI looks better than most Top Picks Winners* in 1 out of 10 key factors.
Accum/Dist: 1.00 (median winner: 1.53)
Above 40wkMA: 20% (median winner: 35%)
Instit. Ownership: 95% (median winner: 63%)
Liquidity: 0.81% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 58.23 (winner: 75.66)
Sales Growth: 11% (median winner: 28%)
Below 52wk High: 3.08% (winner: 3.30%)
Relative Strength: 90 (winner: 96)
Avg Qrtly EPS: -244% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
MMSI EPS/Sales Growth MMSI vs. Peers

OraSure Technologies Inc (OSUR)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.5/1.0
Sales
Consistency

Sales Consistency Ranking

0.7/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

1/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

20%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
52.54
Acc Dist
0.74
Disc
223.68%
Avg Vol
1,031,100
Liquidity
2.33%
Below High
28.81%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
-18%  29%
EPS Growth
131%
Sls Growth
10%
Proj Growth
12.5%
Anal. Rank
4.00
Shares
60.7M
Instit
96%
3-Month Trends of Key Indicators:
Looks Like a Winner?
OSUR looks better than most Top Picks Winners* in 1 out of 10 key factors.
Accum/Dist: 0.74 (median winner: 1.53)
Above 40wkMA: -2% (median winner: 35%)
Instit. Ownership: 96% (median winner: 63%)
Liquidity: 2.33% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 52.54 (winner: 75.66)
Sales Growth: 10% (median winner: 28%)
Below 52wk High: 28.81% (winner: 3.30%)
Relative Strength: 84 (winner: 96)
Avg Qrtly EPS: 5% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

Orasure Technologies Inc: OraSure Technologies is a medical diagnostics company with a focus on point-of-care testing with products that use oral fluid samples and return accurate results in a matter of minutes. By streamlining the sample collection process and improving assay sensitivity, our products significantly improve the way diagnostic testing is conducted. The Company also markets a patented portable cryosurgical system for use by medical professionals in point-of-care settings.

  • OraSure Technologies, Inc.: Fading performance but may be making a comeback? Wed, 22 Nov 2017 16:58:59 +0000
    Categories: Yahoo FinanceOraSure Technologies, Inc. relative valuation is NEUTRAL and it has a fundamental analysis score of 84. Our analysis is based on comparing OraSure Technologies, Inc. with the following peers – Trinity Biotech Plc Sponsored ADR Class A, Cooper Companies, Inc., Riot Blockchain Inc, Quidel Corporation, Response Genetics, Inc., Quest Diagnostics Incorporated, ERBA Diagnostics, Inc., Chembio ... Read more (Read more...)
  • Today’s Research Reports on Stocks to Watch: Medtronic and Orasure Technologies Wed, 22 Nov 2017 13:10:00 +0000
    NEW YORK, NY / ACCESSWIRE / November 22, 2017 / Shares of Medtronic closed up nearly 5% after beating in both the top and bottom line in its second quarter earnings report. Shares of OraSure technologies ...
  • Why OraSure Technologies, Inc. Zoomed Higher Today Tue, 21 Nov 2017 21:23:00 +0000
    A large sale to a single customer has investors excited about the diagnostic company's prospects.
  • Stocks To Watch: Orasure Technologies Sees Relative Strength Rating Jump To 83 Mon, 06 Nov 2017 08:00:00 +0000
    Orasure Technologies shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 70 to 83.
  • Is This Why OraSure Technologies, Inc. Is Tanking Today? Thu, 02 Nov 2017 18:13:00 +0000
    Shares plunged even though the company reported upbeat results. What gives?
  • ETFs with exposure to OraSure Technologies, Inc. : October 20, 2017 Fri, 20 Oct 2017 14:21:35 +0000
    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OraSure Technologies, Inc. Here are 5 ETFs with the largest exposure to OSUR-US. Comparing the performance and risk of OraSure Technologies, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
  • OraSure Technologies, Inc. – Value Analysis (NASDAQ:OSUR) : October 18, 2017 Wed, 18 Oct 2017 14:16:31 +0000
    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives OraSure Technologies, Inc. a score of 84. Our analysis is based on comparing OraSure Technologies, Inc. with the following peers – Trinity Biotech Plc Sponsored ADR Class A, Cooper Companies, Inc., BiOptix, Inc., Quidel Corporation, Response Genetics, Inc., Quest Diagnostics Incorporated, ERBA Diagnostics, Inc., Chembio Diagnostics, Inc., ... Read more (Read more...)
  • OraSure Technologies, Inc. breached its 50 day moving average in a Bearish Manner : OSUR-US : October 17, 2017 Tue, 17 Oct 2017 12:16:00 +0000
    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for OraSure Technologies, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)
  • OraSure Technologies Earnings Conference Call Invitation Wed, 11 Oct 2017 10:00:00 +0000
    BETHLEHEM, Pa., Oct. 11, 2017-- OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2017 third quarter financial results, 2017 fourth quarter financial guidance and certain ...
  • Edwards Lifesciences Pipeline Impressive, Currency Woes Stay Mon, 02 Oct 2017 14:02:02 +0000
    Edwards Lifesciences (EW) rides high on product launches as well as strength in the global Transcatheter Aortic Valve Replacement market.

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
OSUR EPS/Sales Growth OSUR vs. Peers



*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Copyright © 1996-2024 Growth Stock Analytics, LLC. All rights reserved.  Site Map | Privacy Policy | Contact Us